Neuberger Berman Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-769,228	Closed	-$141M	–	1883
2021 Q2	$141M	Sell	769,228 -34,812	-4%	-$5.98M	0.12%	248
2021 Q1	$123M	Sell	804,040 -139,119	-15%	-$21.5M	0.12%	258
2020 Q4	$147M	Sell	943,159 -204,277	-18%	-$26.2M	0.15%	196
2020 Q3	$131M	Buy	1,147,436 +17,301	+2%	+$1.87M	0.16%	186
2020 Q2	$127M	Sell	1,130,135 -155,409	-12%	-$16.5M	0.16%	178
2020 Q1	$115M	Sell	1,285,544 -116,087	-8%	-$11.4M	0.18%	161
2019 Q4	$152M	Sell	1,401,631 -154,455	-10%	-$16.5M	0.18%	165
2019 Q3	$152M	Buy	1,556,086 +387,322	+33%	+$43.7M	0.19%	160
2019 Q2	$153M	Buy	1,168,764 +165,547	+17%	+$21.3M	0.18%	155
2019 Q1	$136M	Buy	1,003,217 +131,073	+15%	+$16.3M	0.17%	177
2018 Q4	$84.9M	Buy	872,144 +286,256	+49%	+$33.8M	0.12%	258
2018 Q3	$81.4M	Buy	585,888 +61,309	+12%	+$7.69M	0.09%	307
2018 Q2	$65.1M	Buy	524,579 +145,400	+38%	+$17M	0.07%	347
2018 Q1	$42.3M	Buy	379,179 +57,591	+18%	+$6.88M	0.05%	447
2017 Q4	$38.5M	Buy	321,588 +50,417	+19%	+$6.14M	0.04%	467
2017 Q3	$38M	Sell	271,171 -1,192	-0.4%	-$162K	0.05%	451
2017 Q2	$33.1M	Buy	272,363 +266,174	+4,301%	+$31M	0.04%	485
2017 Q1	$750K	Buy	6,189 +1,423	+30%	+$183K	﹤0.01%	1210
2016 Q4	$583K	Buy	4,766 +1,980	+71%	+$242K	﹤0.01%	1262
2016 Q3	$341K	Sell	2,786 -1,851	-40%	-$238K	﹤0.01%	1363
2016 Q2	$541K	Buy	+4,637	New	+$658K	﹤0.01%	1231
2014 Q3	–	Sell	-247,836	Closed	-$38.7M	–	1721
2014 Q2	$38.7M	Sell	247,836 -7,498	-3%	-$1.18M	0.04%	495
2014 Q1	$38.8M	Sell	255,334 -2,136	-0.8%	-$340K	0.04%	477
2013 Q4	$34.2M	Buy	257,470 +42,092	+20%	+$5.05M	0.04%	496
2013 Q3	$25M	Sell	215,378 -30,424	-12%	-$3.34M	0.03%	569
2013 Q2	$22.7M	Buy	+245,802	New	+$23.7M	0.03%	570

Other funds holding ALXN